1. Home
  2. REVB vs NVFY Comparison

REVB vs NVFY Comparison

Compare REVB & NVFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REVB
  • NVFY
  • Stock Information
  • Founded
  • REVB 2020
  • NVFY 2003
  • Country
  • REVB United States
  • NVFY United States
  • Employees
  • REVB N/A
  • NVFY N/A
  • Industry
  • REVB Biotechnology: Pharmaceutical Preparations
  • NVFY Home Furnishings
  • Sector
  • REVB Health Care
  • NVFY Consumer Discretionary
  • Exchange
  • REVB Nasdaq
  • NVFY Nasdaq
  • Market Cap
  • REVB 3.1M
  • NVFY 3.6M
  • IPO Year
  • REVB N/A
  • NVFY N/A
  • Fundamental
  • Price
  • REVB $0.80
  • NVFY $0.70
  • Analyst Decision
  • REVB
  • NVFY
  • Analyst Count
  • REVB 0
  • NVFY 0
  • Target Price
  • REVB N/A
  • NVFY N/A
  • AVG Volume (30 Days)
  • REVB 1.3M
  • NVFY 45.5K
  • Earning Date
  • REVB 11-08-2024
  • NVFY 11-14-2024
  • Dividend Yield
  • REVB N/A
  • NVFY N/A
  • EPS Growth
  • REVB N/A
  • NVFY N/A
  • EPS
  • REVB N/A
  • NVFY N/A
  • Revenue
  • REVB N/A
  • NVFY $9,955,064.00
  • Revenue This Year
  • REVB N/A
  • NVFY N/A
  • Revenue Next Year
  • REVB N/A
  • NVFY N/A
  • P/E Ratio
  • REVB N/A
  • NVFY N/A
  • Revenue Growth
  • REVB N/A
  • NVFY N/A
  • 52 Week Low
  • REVB $0.70
  • NVFY $0.67
  • 52 Week High
  • REVB $25.26
  • NVFY $6.38
  • Technical
  • Relative Strength Index (RSI)
  • REVB 44.03
  • NVFY 27.15
  • Support Level
  • REVB $0.80
  • NVFY $0.90
  • Resistance Level
  • REVB $1.05
  • NVFY $1.17
  • Average True Range (ATR)
  • REVB 0.07
  • NVFY 0.11
  • MACD
  • REVB -0.00
  • NVFY -0.03
  • Stochastic Oscillator
  • REVB 9.69
  • NVFY 5.64

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of therapies for the prevention and treatment of disease using trained immunity. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

About NVFY Nova Lifestyle Inc.

Nova Lifestyle Inc is a designer and lifestyle furniture company. It distributes and retails contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. Its customers mainly comprise distributors and retailers having specific geographic coverages that deploy middle to high-end private label home furnishings. The company operates in one business and industry segment: the design and sale of furniture.

Share on Social Networks: